RecruitingPhase 2NCT05441813

Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy

A Randomized, Open-label Study of Coconut Oil Mouth Rinse for Prophylaxis of Severe Oral Mucositis in Pediatric Patients Receiving Myeloablative Conditioning Regimens


Sponsor

Wake Forest University Health Sciences

Enrollment

60 participants

Start Date

Feb 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to learn if virgin coconut oil (VCO) mouth rinse can help prevent oral mucositis. The Study Investigator will compare standard of care mucositis prevention rinses with the VCO mouth rinse added to the standard of care mucositis prevention rinses. The severity of oral mucositis between the 2 groups will be evaluated. Some of the standard of care rinses that can be used to prevent mucositis are normal saline, Benadryl (diphenhydramine), Mylanta, lidocaine, or other combinations.


Eligibility

Min Age: 7 YearsMax Age: 26 Years

Inclusion Criteria7

  • Written informed consent, HIPAA authorization for release of personal health information, and assent, when applicable from the subject, parent, or legal guardian.
  • Age greater than or equal to 7 years to 26 years at the time of consent
  • Patients planning to undergo myeloablative conditioning regimens in preparation for HSCT
  • ECOG Performance Status of less than or equal to 2 or Lansky/Karnofsky Performance Status of greater than or equal to 50 within 7 days prior to date of enrollment.
  • No evidence of mouth lesions at time of enrollment
  • Ability of the subject and parent/caregiver to understand and comply with study procedures for the entire length of the study
  • Able and willing to swish/spit the oral formulation

Exclusion Criteria6

  • Subjects meeting any of the criteria below may not participate in the study:
  • Allergy to tree nuts
  • Planned discharge home prior to engraftment
  • Using coconut oil mouth rinses within 30 days prior to enrollment
  • Using additional mouthcare regimens, other than those allowed in the institutional SOP, prior to admission with a plan to continue use during admission
  • Patient has undergone HSCT within the last 90 days prior to admission

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVirgin Coconut Oil

Standard of care with the addition of virgin coconut oil mouth rinse


Locations(1)

Atrium Health Levine Children's Hospital

Charlotte, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05441813


Related Trials